Tandlægeselskabet Holm-Christoffersen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.0% 0.8% 0.9% 0.8% 0.7%  
Credit score (0-100)  87 93 89 93 94  
Credit rating  A AA A AA AA  
Credit limit (kDKK)  240.6 679.6 677.7 945.2 772.5  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  5,265 7,247 8,249 9,866 11,570  
EBITDA  898 2,502 1,808 2,378 2,991  
EBIT  856 2,453 1,733 2,295 2,457  
Pre-tax profit (PTP)  825.2 2,412.8 1,620.5 2,308.3 2,365.5  
Net earnings  647.1 1,887.8 1,254.8 1,800.7 1,838.4  
Pre-tax profit without non-rec. items  825 2,413 1,621 2,308 2,366  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  409 481 446 551 4,202  
Shareholders equity total  2,198 3,975 4,480 5,781 3,869  
Interest-bearing liabilities  0.1 0.2 0.1 2.9 0.5  
Balance sheet total (assets)  5,227 6,587 7,358 8,305 6,518  

Net Debt  -1,733 -3,087 -4,143 -5,510 -1,900  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,265 7,247 8,249 9,866 11,570  
Gross profit growth  6.9% 37.6% 13.8% 19.6% 17.3%  
Employees  9 9 11 11 12  
Employee growth %  12.5% 0.0% 22.2% 0.0% 9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,227 6,587 7,358 8,305 6,518  
Balance sheet change%  37.9% 26.0% 11.7% 12.9% -21.5%  
Added value  897.6 2,502.5 1,808.3 2,370.8 2,990.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  368 24 -110 22 3,117  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  16.3% 33.9% 21.0% 23.3% 21.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.6% 43.0% 26.1% 31.9% 33.4%  
ROI %  47.8% 81.7% 42.7% 48.4% 49.0%  
ROE %  33.6% 61.2% 29.7% 35.1% 38.1%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  41.0% 60.5% 61.5% 69.9% 59.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -193.0% -123.3% -229.1% -231.7% -63.5%  
Gearing %  0.0% 0.0% 0.0% 0.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  5,330.5% 81,992.9% 113,461.9% 12,440.3% 6,533.3%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.6 1.5 1.8 2.5 1.1  
Current Ratio  1.6 1.5 1.7 2.4 1.0  
Cash and cash equivalent  1,732.7 3,086.8 4,143.4 5,513.2 1,900.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,731.2 634.7 2,045.8 1,925.5 68.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  100 278 164 216 249  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  100 278 164 216 249  
EBIT / employee  95 273 158 209 205  
Net earnings / employee  72 210 114 164 153